Which patients receive antidepressants? A 'real world' telephone study

Journal of Affective Disorders

Volumn 49, Issue 1, 1998, Pages 19-26

  Bouhassira, M ^a   Allicar, M P ^b   Blachier, C ^c   Nouveau, A ^d   Rouillon, F ^e  

^a Med Dept Lilly France 203 B   (France)

^b Pharmaco epidemiologist   (France)

^c Economist   (France)

^d EVAL   (France)

^e HÔPITAL LOUIS MOURIER   (France)

Author keywords

Antidepressant; Cross sectional survey; Drug utilization review; General population; Pharmacoepidemiology; Prescription

Indexed keywords

AMINEPTINE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CLOMIPRAMINE; FLUOXETINE; MAPROTILINE; MIANSERIN; TIANEPTINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; DEPRESSION; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; TELEPHONE;

ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANXIETY DISORDERS; CHI-SQUARE DISTRIBUTION; DATABASES, FACTUAL; DEPRESSIVE DISORDER; DRUG THERAPY, COMBINATION; DRUG UTILIZATION REVIEW; FEMALE; FLUOXETINE; FRANCE; HEALTH CARE SURVEYS; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MEDICATION ERRORS; PHYSICIAN'S PRACTICE PATTERNS; PREVALENCE; SAMPLING STUDIES; TELEPHONE;

EID: 0032053390     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(97)00193-6     Document Type: Article

References (19)

1. Angst J. Epidemiology of depression. Psychopharmacology. 106:1992;S71-S74.
2. Barondes S. Thinking about Prozac. Science. 263:1994;1102.
3. Freeman H. Listening to Prozac - Correspondence. Nature. 369:1994;178.
4. Isacsson G., Boëthius G., Begman U. Low level of antidepressant prescription for people who later commit suicide: 15 years of experience from a population-based drug database in Sweden. Acta Psychiatr. Scand. 85:1992;444-448.
5. Kaplan R. Listening to Prozac - Correspondence. Nature. 369:1994;178.
6. Kramer, P.D. (1993). Listening to Prozac. A psychiatrist explores antidepressant drugs and the remaking of the self. Viking: New York.
7. Lecrubier Y., Sheehan D.V., Weiller E., Amorim P., Bonara I., Sheehan K.H., Janavs J., Dunbar G.C. The Mini International Neuropsychiatric Interview (MINI) a short diagnostic structured interview: reliability and validity according to the CIDI. Am. J. Psychiatry. 12:1997;224-231.
8. Manolis D.C. The perils of Prozac. Minnesota Med. 78:1995;19-23.
9. Medawar C. Through the doors of deception? Nature. 368:1994;369.
10. Montgomery S.A., Kasper S. Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. Int. Clin. Psychopharmacol. 9(suppl 4):1995;33-40.
11. Munizza C., Tibaldi G., Bollini P., Pirfo E., Punzo F., Gramaglia F. Prescription pattern of antidepressants in out-patient psychiatric practice. Psychol. Med. 25:1995;771-778.
12. Olfson M., Klerman G.L. Trends in the prescription of antidepressants by office-based psychiatrists. Am. J. Psychiatry. 150:1993;571-577.
13. Rickels K., Downing R., Scweizer E., Hassman H. Antidepressants for the treatment of generalized anxiety disorder. Arch. Gen. Psychiatry. 50:1993;884-895.
14. Rosholm J.U., Hallas J., Gram L.F. Outpatient utilization of antidepressants: a prescription database analysis. J. Affect. Disord. 27:1993;21-28.
15. Sheehan D.V., Lecrubier Y., Sheehan K.H., Janavs J., Weiller E., Keskiner A., Schinka J., Knapp E., Sheehan M.F., Dunbar G.C. Reliability and validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P. American Journal of Psychiatry. 12:1996;232-241.
16. Simon G., VonKorff M., Barlow W. Health care costs of primary care patients with recognized depression. Arch. Gen. Psychiatry. 52:1995;850-856.
17. Simon G., Wagner E., VonKorff M. Cost-effectiveness comparisons using 'real world' randomized trials: the case of new antidepressant drugs. J. Clin. Epidemiol. 48:1995;363-373.
18. Walder J. Listening to Prozac - Correspondence. Nature. 369:1994;178.
19. Wells K.B., Katon W., Rogers B., Camp P. Use of minor tranquilizers and antidepressant medications by depressed outpatients: results from the medical outcomes study. Am. J. Psychiatry. 151:1994;694-700.